Tax in the news – impacts on biotech and tech companies

Latest tax updates

UK Patent Box, The Modified Nexus approach Position as at March 2015

By colinhailey | April 7, 2015

XO1 acquired by Janssen Pharmaceutical Companies of Johnson & Johnson

By colinhailey | March 19, 2015

        Confluence Tax is delighted to have assisted XO1 with its sale to Janssen Pharmaceuticals. Click here to view article Commenting on our role, Richard Mason, CEO of XO1, said: “Confluence Tax LLP are clearly streets ahead of everybody, including the big 4 firms, when it comes to providing professional taxation advice in…

Budget 2015

By colinhailey | March 19, 2015

18 March 2015 The major changes relevant to technology and biotechnology companies announced in the 2015 Budget are set out below. R&D Tax Credits There are no new announcements regarding R&D tax credit rates. Following a consultation, a number of measures are to be introduced to encourage take­‐up  by smaller  businesses, including new guidance for…

Autumn Statement 2014

By colinhailey | December 4, 2014

3 December 2014 The major changes relevant to technology and biotechnology companies announced in the Autumn Statement are set out below. We will get further details over the next few days. R&D Tax Credits i. Increase in rates The SME and large company R&D tax credit rates are uplifted from 1 April 2015. For SMEs…

Confluence Tax assists F-star Alpha on asset centric deal with Bristol-Myers Squibb

By colinhailey | November 3, 2014

          Bristol-Myers Squibb Enters into Agreement that Provides an Exclusive Option to Acquire F-star Alpha Ltd. and its Novel HER2-Targeted Therapy

Budget 2014

By colinhailey | March 20, 2014

Overview The intention to rebalance the economy and encourage investment has resulted in a budget for 2014 which provides targeted rewards for certain activities. The likely taxpayers in the technology and life science sectors who are affected are highlighted below. Areas which are unaffected are as follows: • Employee share incentives such as EMI options.…

Colin Hailey talks to Pharma TV about UK R&D tax credits

By colinhailey | January 7, 2014

Budget 2013

By colinhailey | March 21, 2013

Overview There were few changes specifically relevant to technology and biotechnology companies announced in the 2013 Budget. Many measures are now announced as intentions for future fiscal years, with details provided just prior to introduction. This note therefore comments on key measures announced today, as well as measures announced previously but only just coming into…